The Role of Narrow-Band Imaging Endoscopy in Diagnosing Gastric Intestinal Metaplasia
May 5, 2008 updated by: Hillel Yaffe Medical Center
Observational: Studies in Human Beings Health Outcomes
The purpose of this study is to determine if endoscope with NBI(narrow banding imaging)can detect intestinal metaplasia( consider pre malignant condition) and use a targeting biopsy in case of suspected intestinal metaplasia
Study Overview
Detailed Description
To detect intestinal metaplasia which consider pre malignant condition and use a targeting biopsy in case of suspected intestinal metaplasia which allowed us to better follow-up those patients.
Study Type
Observational
Enrollment (Anticipated)
70
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Hadera, Israel, 38100
- Hillel Yaffe Med Ctr
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Hundred consecutive dyspeptic patients
Description
Inclusion Criteria:
- Dyspepsia
Exclusion Criteria:
- Pregnancy,
- Upper gastrointestinal bleeding,
- Previous gastric operation,
- Known gastric malignancy'
- Non cooperative patients
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Case-Control
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
A
Seventy dyspeptic consecutive patients that going upper gastrointestinal endoscopy
|
Using upper gastrointestinal endoscopy with targeting biopsy in patients with dyspepsia
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
To determine if endoscope with NBI can detect intestinal metaplasia
Time Frame: In one week (the time from biopsy till the histology assement)
|
In one week (the time from biopsy till the histology assement)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Zvi Fireman, MD, Hillel Yaffe Med Ctr
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2008
Primary Completion (Anticipated)
January 1, 2009
Study Completion (Anticipated)
February 1, 2009
Study Registration Dates
First Submitted
May 5, 2008
First Submitted That Met QC Criteria
May 5, 2008
First Posted (Estimate)
May 7, 2008
Study Record Updates
Last Update Posted (Estimate)
May 7, 2008
Last Update Submitted That Met QC Criteria
May 5, 2008
Last Verified
May 1, 2008
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- HY-07/2008
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.